DRUG-seq for miniaturized high-throughput transcriptome profiling in drug discovery
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
DRUG-seq for miniaturized high-throughput transcriptome profiling in drug discovery ; volume:9 ; number:1 ; day:17 ; month:10 ; year:2018 ; pages:1-9 ; date:12.2018
Nature Communications ; 9, Heft 1 (17.10.2018), 1-9, 12.2018
- Urheber
-
Ye, Chaoyang
- Beteiligte Personen und Organisationen
-
Ho, Daniel J.
Neri, Marilisa
Yang, Chian
Kulkarni, Tripti
Randhawa, Ranjit
Henault, Martin
Mostacci, Nadezda
Farmer, Pierre
Renner, Steffen
Ihry, Robert
Mansur, Leandra
Keller, Caroline Gubser
McAllister, Gregory
Hild, Marc
Jenkins, Jeremy
Kaykas, Ajamete
SpringerLink (Online service)
- DOI
-
10.1038/s41467-018-06500-x
- URN
-
urn:nbn:de:101:1-2018111923460270884859
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.08.20252025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ye, Chaoyang
- Ho, Daniel J.
- Neri, Marilisa
- Yang, Chian
- Kulkarni, Tripti
- Randhawa, Ranjit
- Henault, Martin
- Mostacci, Nadezda
- Farmer, Pierre
- Renner, Steffen
- Ihry, Robert
- Mansur, Leandra
- Keller, Caroline Gubser
- McAllister, Gregory
- Hild, Marc
- Jenkins, Jeremy
- Kaykas, Ajamete
- SpringerLink (Online service)
Ähnliche Objekte (12)
Advances in high‐throughput mass spectrometry in drug discovery
Repurposing FDA‐Approved Drugs for Temozolomide‐Resistant IDH1 Mutant Glioma Using High‐Throughput Miniaturized Screening on Droplet Microarray Chip
Targeting HIV-1 Protease Autoprocessing for High-throughput Drug Discovery and Drug Resistance Assessment
High-Throughput Chromatographic Approaches to Assess Drug Partition into Biomembranes
High‐throughput metabolomics predicts drug–target relationships for eukaryotic proteins
Droplet‐Microarray: Miniaturized Platform for High‐Throughput Screening of Antimicrobial Compounds
High‐Throughput Screening of Cell Transfection Enhancers Using Miniaturized Droplet Microarrays
Fish Capsules: A System for High‐Throughput Screening of Combinatorial Drugs
Retinal Organoids: A Next-Generation Platform for High-Throughput Drug Discovery
ReSeq simulates realistic Illumina high-throughput sequencing data
RELACS nuclei barcoding enables high-throughput ChIP-seq
Methods for high-throughput MethylCap-Seq data analysis
Advances in high‐throughput mass spectrometry in drug discovery
Repurposing FDA‐Approved Drugs for Temozolomide‐Resistant IDH1 Mutant Glioma Using High‐Throughput Miniaturized Screening on Droplet Microarray Chip
Targeting HIV-1 Protease Autoprocessing for High-throughput Drug Discovery and Drug Resistance Assessment
High-Throughput Chromatographic Approaches to Assess Drug Partition into Biomembranes
High‐throughput metabolomics predicts drug–target relationships for eukaryotic proteins
Droplet‐Microarray: Miniaturized Platform for High‐Throughput Screening of Antimicrobial Compounds
High‐Throughput Screening of Cell Transfection Enhancers Using Miniaturized Droplet Microarrays
Fish Capsules: A System for High‐Throughput Screening of Combinatorial Drugs
Retinal Organoids: A Next-Generation Platform for High-Throughput Drug Discovery
ReSeq simulates realistic Illumina high-throughput sequencing data
RELACS nuclei barcoding enables high-throughput ChIP-seq
Methods for high-throughput MethylCap-Seq data analysis
Advances in high‐throughput mass spectrometry in drug discovery
Repurposing FDA‐Approved Drugs for Temozolomide‐Resistant IDH1 Mutant Glioma Using High‐Throughput Miniaturized Screening on Droplet Microarray Chip
Targeting HIV-1 Protease Autoprocessing for High-throughput Drug Discovery and Drug Resistance Assessment
High-Throughput Chromatographic Approaches to Assess Drug Partition into Biomembranes
High‐throughput metabolomics predicts drug–target relationships for eukaryotic proteins
Droplet‐Microarray: Miniaturized Platform for High‐Throughput Screening of Antimicrobial Compounds
High‐Throughput Screening of Cell Transfection Enhancers Using Miniaturized Droplet Microarrays
Fish Capsules: A System for High‐Throughput Screening of Combinatorial Drugs
Retinal Organoids: A Next-Generation Platform for High-Throughput Drug Discovery
ReSeq simulates realistic Illumina high-throughput sequencing data
RELACS nuclei barcoding enables high-throughput ChIP-seq